Bank of New York Mellon Corp Has $7.85 Million Stock Position in Astrana Health, Inc. (NASDAQ:ASTH)

Bank of New York Mellon Corp decreased its position in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 5.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 253,252 shares of the company's stock after selling 13,624 shares during the quarter. Bank of New York Mellon Corp owned about 0.51% of Astrana Health worth $7,853,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Quantbot Technologies LP lifted its holdings in shares of Astrana Health by 152.5% in the fourth quarter. Quantbot Technologies LP now owns 10,651 shares of the company's stock valued at $336,000 after buying an additional 6,433 shares during the period. JPMorgan Chase & Co. raised its position in shares of Astrana Health by 136.1% during the fourth quarter. JPMorgan Chase & Co. now owns 163,532 shares of the company's stock worth $5,156,000 after purchasing an additional 94,268 shares during the period. Two Sigma Investments LP acquired a new stake in shares of Astrana Health during the fourth quarter worth $466,000. KLP Kapitalforvaltning AS acquired a new position in Astrana Health during the fourth quarter valued at $318,000. Finally, Wells Fargo & Company MN increased its position in Astrana Health by 41.5% in the 4th quarter. Wells Fargo & Company MN now owns 22,484 shares of the company's stock worth $709,000 after purchasing an additional 6,596 shares during the last quarter. Institutional investors and hedge funds own 52.77% of the company's stock.

Analysts Set New Price Targets

Separately, Barclays started coverage on Astrana Health in a research report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $53.29.

Astrana Health Stock Performance

NASDAQ:ASTH traded up $0.89 during mid-day trading on Friday, hitting $23.39. 121,279 shares of the company's stock traded hands, compared to its average volume of 314,047. The firm has a 50 day moving average of $24.90 and a two-hundred day moving average of $29.91. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 0.54. Astrana Health, Inc. has a 12 month low of $22.45 and a 12 month high of $63.20. The firm has a market capitalization of $1.31 billion, a price-to-earnings ratio of 32.49, a price-to-earnings-growth ratio of 0.86 and a beta of 0.84.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.09). Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The company had revenue of $620.39 million for the quarter, compared to the consensus estimate of $628.11 million. During the same quarter last year, the business earned $0.31 EPS. Astrana Health's quarterly revenue was up 53.4% compared to the same quarter last year. On average, equities analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.